January 14, 2026

Strive Specialties, Inc. v. Eli Lilly & Company et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 23, 2026

    Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

    A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1 medications, saying Strive's claim that the court committed a manifest legal error was based on the company's own misunderstanding.

5 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login